EPIX Pharmaceuticals, Inc.

Strategic shifts by Merrimack Pharmaceuticals Inc. and Vical Inc. took different turns during the last week of August, which was predictably quiet ahead of the long Labor Day weekend in the US in

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Parvus, Genentech Collaborat

IN VITRO DIAGNOSTICS Financings HTG Molecular Diagnostics Inc. HTG Molecular Diagnostics Inc. netted $37.9mm through a public offering of 13.9mm common shares (including the overallotment) at $2.9

ESSA Pharma Inc. is the first company to enter the clinic with a drug program based on a new mechanism of action targeting the N-terminal domain of androgen receptors in metastatic castration-resist